Download Leukaemia Section t(11;14)(q23;q32) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Intrinsically disordered proteins wikipedia , lookup

Proteomics wikipedia , lookup

Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup

Bimolecular fluorescence complementation wikipedia , lookup

Protein purification wikipedia , lookup

Protein mass spectrometry wikipedia , lookup

Protein domain wikipedia , lookup

Western blot wikipedia , lookup

Protein structure prediction wikipedia , lookup

Protein–protein interaction wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Mini Review
t(11;14)(q23;q32)
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: July 2009
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1114q23q32ID1539.html
DOI: 10.4267/2042/44785
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Disease
were ascertained. The BAL case showed a complex
karyotype with -7 and i(17q), the ALL case also had a
complex karyotype, with +12.
Treatment related leukemia (treatment related acute
myeloid leukemia, t-AML)
Genes involved and proteins
Epidemiology
MLL
The involvement of MLL in 11q23 and KIAA0284 in
14q32 was shown in only 2 cases (Burmeister et al.,
2008; De Braekeleer et al., 2009). These 2 cases were
treatment related leukemia cases (t-AML for: treatment
related acute myeloid leukemia). These t-AML cases
occurred in a 45-year-old male patient (a M1 case) and
in a 65-year-old female patient, 2 years after an
urothelial carcinoma and 5 years after a ductal
mammary carcinoma respectively. In 1 other case of
t(11;14)(q23;q32), a myelodysplastic syndrome case,
the involvement of MLL was excluded, and IGH in
14q32 was rearranged (Yujiri et al., 2009). Finally, in 2
other cases of t(11;14)(q23;q32), no molecular studies
were available (Kaneko et al., 1982; Hanson et al.,
1993). The two latter cases were a biphenotypic
leukemia (BAL) case and an acute lymphoblastic
leukemia (ALL) in a 33-year-old male patient.
Location
11q23
DNA/RNA
36 exons, multiple transcripts 13-15 kb.
Protein
3969 amino acids; 431 kDa; contains two DNA binding
motifs (a AT hook and a CXXC domain), a DNA
methyl transferase motif, a bromodomain. MLL is
cleaved by taspase 1 into 2 proteins before entering the
nucleus, called MLL-N and MLL-C. The FYRN and a
FRYC domains of native MLL associate MLL-N and
MLL-C in a stable complex; they form a multiprotein
complex with transcription factor TFIID. MLL is a
transcriptional regulatory factor. MLL can be
associated with more than 30 proteins, including the
core components of the SWI/SNF chromatin
remodeling complex and the transcription complex
TFIID. MLL binds promotors of HOX genes through
acetylation and methylation of histones. MLL is a
major regulator of hematopoesis and embryonic
development.
Clinics and pathology
Prognosis
One of the t-AML cases died 2 months after diagnosis,
while the other one was lost to follow-up 5 years after
diagnosis of the t-AML. The ALL case died 7 months
after diagnosis.
KIAA0284
Cytogenetics S
Location
14q32.33
Protein
KIAA0284 presents an amino acids similarity of
30% with CEP170. CEP170 is a forkhead-associated
Cytogenetics morphological
The t(11;14)(q23;q32) was the sole anomaly in the 2
cases were MLL and KIAA0284 involvements
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(6)
593
t(11;14)(q23;q32)
Huret JL
domain protein which associates with centrosomes
during interphase and with spindle microtubules during
mitosis (Guarguaglini et al., 2005).
Hanson CA, Abaza M, Sheldon S, Ross CW, Schnitzer B,
Stoolman
LM.
Acute
biphenotypic
leukaemia:
immunophenotypic and cytogenetic analysis. Br J Haematol.
1993 May;84(1):49-60
Result of the chromosomal
anomaly
Guarguaglini G, Duncan PI, Stierhof YD, Holmström T,
Duensing S, Nigg EA. The forkhead-associated domain protein
Cep170 interacts with Polo-like kinase 1 and serves as a
marker for mature centrioles. Mol Biol Cell. 2005
Mar;16(3):1095-107
Hybrid gene
Burmeister T, Meyer C, Thiel G, Reinhardt R, Thiel E,
Marschalek R. A MLL-KIAA0284 fusion gene in a patient with
secondary acute myeloid leukemia and t(11;14)(q23;q32).
Blood Cells Mol Dis. 2008 Sep-Oct;41(2):210-4
Description
5' MLL - 3' KIAA0284
Transcript
The breakpoint was located in intron 9 of MLL. The
breakpoint in KIAA0284 was located in intron 2 in one
case, and intron 4 in the other case.
De Braekeleer E, Ianotto JC, Douet-Guilbert N, Meyer C, Morel
F, Le Bris MJ, Marschalek R, Berthou C, Férec C, De
Braekeleer M. A second case of secondary acute myeloblastic
leukemia associated with the MLL-KIAA0284 fusion gene.
Blood Cells Mol Dis. 2009 May-Jun;42(3):292-3
Fusion protein
Description
N-term MLL - C-term KIAA0284
Yujiri T, Miyazaki M, Imoto S. A novel t(11;14)(q23;q32) in a
case of myelodysplastic syndrome. Cancer Genet Cytogenet.
2009 Jan 15;188(2):124-5
References
This article should be referenced as such:
Huret JL. t(11;14)(q23;q32). Atlas Genet Cytogenet Oncol
Haematol. 2010; 14(6):593-594.
Kaneko Y, Rowley JD, Variakojis D, Chilcote RR, Check I,
Sakurai M. Correlation of karyotype with clinical features in
acute lymphoblastic leukemia. Cancer Res. 1982
Jul;42(7):2918-29
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(6)
594
Related documents
Leukaemia Section t(3;11)(p21;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;11)(p21;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;20)(q23;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;20)(q23;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section DAB2IP (DAB2 interacting protein) Atlas of Genetics and Cytogenetics
Gene Section DAB2IP (DAB2 interacting protein) Atlas of Genetics and Cytogenetics
Leukaemia Section t(11;22)(q23;q13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;22)(q23;q13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(q22;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(q22;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(p11.2;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(p11.2;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;11)(q34;q23) AF9q34/MLL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;11)(q34;q23) AF9q34/MLL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;11)(q13;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;11)(q13;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(X;11)(q22;q23)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(X;11)(q22;q23) Atlas of Genetics and Cytogenetics
Leukaemia Section t(X;11)(q13;q23)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(X;11)(q13;q23) Atlas of Genetics and Cytogenetics
Gene Section SEPT6 (septin 6) Atlas of Genetics and Cytogenetics
Gene Section SEPT6 (septin 6) Atlas of Genetics and Cytogenetics
Gene Section AF9 (ALL1 fused gene from chromosome 9)
Gene Section AF9 (ALL1 fused gene from chromosome 9)
Gene Section AF15q14 (ALL1 fused gene from 15q14) in Oncology and Haematology
Gene Section AF15q14 (ALL1 fused gene from 15q14) in Oncology and Haematology
Leukaemia Section t(11;19)(q23;p13.3) MLL/ACER1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;19)(q23;p13.3) MLL/ACER1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section AF4p12 (ALL1 fused gene from chromosome 4p12)
Gene Section AF4p12 (ALL1 fused gene from chromosome 4p12)
Gene Section AF17 (ALL1 fused gene from chromosome 17)
Gene Section AF17 (ALL1 fused gene from chromosome 17)
Leukaemia Section inv(11)(q13q23)  Atlas of Genetics and Cytogenetics
Leukaemia Section inv(11)(q13q23) Atlas of Genetics and Cytogenetics
Leukaemia Section t(10;11)(p12;q23) KMT2A/NEBL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(p12;q23) KMT2A/NEBL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;11)(p32;q23)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;11)(p32;q23) Atlas of Genetics and Cytogenetics
eCSI Case Discussion
eCSI Case Discussion